5KOQ
Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.3 |
Synchrotron site | ALS |
Beamline | 5.0.3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-02-28 |
Detector | ADSC QUANTUM 4r |
Wavelength(s) | 1.0 |
Spacegroup name | P 21 3 |
Unit cell lengths | 138.562, 138.562, 138.562 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 50.000 - 2.700 |
R-factor | 0.2063 |
Rwork | 0.204 |
R-free | 0.25150 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.008 |
RMSD bond angle | 1.272 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0135) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 2.780 |
High resolution limit [Å] | 2.700 | 6.180 | 2.700 |
Rmerge | 0.071 | 0.027 | 0.721 |
Total number of observations | 145758 | ||
Number of reflections | 24640 | ||
<I/σ(I)> | 11.6 | ||
Completeness [%] | 100.0 | 99.9 | 100 |
Redundancy | 5.9 | 5.8 | 6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.6 | 293 | 23% PEG600, 100 mM citric acid |